Anti-GRAN/ GCA/ GCL monoclonal antibody

Anti-GRAN/ GCA/ GCL antibody for FACS & in-vivo assay

Target products collectionGo to GCA/GCA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2140-Ab-1/ GM-Tg-hg-MP2140-Ab-2Anti-Human GCA monoclonal antibodyHuman
GM-Tg-rg-MP2140-Ab-1/ GM-Tg-rg-MP2140-Ab-2Anti-Rat GCA monoclonal antibodyRat
GM-Tg-mg-MP2140-Ab-1/ GM-Tg-mg-MP2140-Ab-2Anti-Mouse GCA monoclonal antibodyMouse
GM-Tg-cynog-MP2140-Ab-1/ GM-Tg-cynog-MP2140-Ab-2Anti-Cynomolgus/ Rhesus macaque GCA monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2140-Ab-1/ GM-Tg-felg-MP2140-Ab-2Anti-Feline GCA monoclonal antibodyFeline
GM-Tg-cang-MP2140-Ab-1/ GM-Tg-cang-MP2140-Ab-2Anti-Canine GCA monoclonal antibodyCanine
GM-Tg-bovg-MP2140-Ab-1/ GM-Tg-bovg-MP2140-Ab-2Anti-Bovine GCA monoclonal antibodyBovine
GM-Tg-equg-MP2140-Ab-1/ GM-Tg-equg-MP2140-Ab-2Anti-Equine GCA monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2140-Ab-1/ GM-Tg-hg-MP2140-Ab-2; GM-Tg-rg-MP2140-Ab-1/ GM-Tg-rg-MP2140-Ab-2;
GM-Tg-mg-MP2140-Ab-1/ GM-Tg-mg-MP2140-Ab-2; GM-Tg-cynog-MP2140-Ab-1/ GM-Tg-cynog-MP2140-Ab-2;
GM-Tg-felg-MP2140-Ab-1/ GM-Tg-felg-MP2140-Ab-2; GM-Tg-cang-MP2140-Ab-1/ GM-Tg-cang-MP2140-Ab-2;
GM-Tg-bovg-MP2140-Ab-1/ GM-Tg-bovg-MP2140-Ab-2; GM-Tg-equg-MP2140-Ab-1/ GM-Tg-equg-MP2140-Ab-2
Products NameAnti-GCA monoclonal antibody
Formatmab
Target NameGCA
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GCA benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species GRAN/ GCA/ GCL VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP004796human GCA Lentivirus plasmid
    ORF Viral VectorvGMLP004796human GCA Lentivirus particle
    ORF Viral VectorpGMLPm000840mouse Gca Lentivirus plasmid
    ORF Viral VectorvGMLPm000840mouse Gca Lentivirus particle


    Target information

    Target IDGM-MP2140
    Target NameGCA
    Gene ID25801,227960,295647,702138,608208,101098073,507139,100051621
    Gene Symbol and Synonyms5133401E04Rik,GCA,GCL
    Uniprot AccessionP28676
    Uniprot Entry NameGRAN_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000115271
    Target ClassificationN/A

    The target: GCA, gene name: GCA, also named as GCL. This gene encodes a calcium-binding protein that is abundant in neutrophils and macrophages. In the absence of divalent cation, this protein localizes to the cytosolic fraction; with magnesium alone, it partitions with the granule fraction; and in the presence of magnesium and calcium, it associates with both the granule and membrane fractions. Alternative splicing and use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Aug 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.